Location: Geneva, Switzerland Working time: full-time Working from home: possible, subject to HR Policy Travel requirements: occasional, less than 5% of the overall working time.
The Medicines Patent Pool (MPP) is a United Nations-backed public health organisation working to increase access to, and facilitate the development of, life-saving medicines for low- and middle-income countries (LMICs). Through its innovative business model, MPP partners with civil society, governments, international organisations, industry, patient groups, and other stakeholders to prioritise and license needed medicines and pool intellectual property to encourage generic manufacture and the development of new formulations. MPP’s mandate covers patented medicines for infectious diseases – HIV, TB, hepatitis C and also non-communicable diseases including cancer, cardiovascular diseases and diabetes, in addition to COVID-19 treatments and technologies.
MPP operates as a non-profit voluntary licensing mechanism through partnerships with originator pharmaceutical companies and generic manufacturers that facilitate access and promote innovation. The terms and conditions in MPP licences seek to improve treatment options for the broadest number of people living in LMICs and are negotiated on a case-by-case basis with each patent holder.
Positively impacting peoples’ lives is one of the main goals of MPP activities. MPP’s impact assessment is based on country-level modelling and contrasting MPP’s contribution to alternative scenarios where key WHO-recommended medicines would not have been available through MPP licences. For further information regarding our work, please visit our website
MPP is a small but impactful organisation with a dedicated team of 50 professionals. Our success is built on strong, collaborative partnerships across diverse sectors, including private, public, research and academia, civil society organisations, and patients’ advocacy groups. As MPP Associate Counsel, you will work as part of a small team of four professionals, under direct management of the General Counsel. You will support MPP’s operations across all areas, from in- and out- licensing, policy, product development and technology transfer, grants and donors’ relations, procurement etc.
To thrive in this role, you must be proactive, self-motivated, and able to work autonomously. You will engage with MPP staff across the organisation, as well as with external partners. You must be comfortable handling a wide range of legal matters and interacting with people who have a deep legal expertise, as well as with those who have limited or no legal background.
MPP’s richness lies in its staff: a small dynamic and multicultural team. To flourish in our team, you must recognise yourself in our values: Respect, Courage, Generosity and Commitment.
Moreover, the Associate Counsel will need to demonstrate:
MPP respects all individuals regardless of race, gender, ethnicity, sexual orientation, religion, HIV status or disability. All qualified applications are welcome.
If you recognize yourself in this description, please send a cover letter and C.V. to recruitment@medicinespatentpool.org including “Associate Counsel” as reference in the subject line by 17 August 2025
Press and Media
The Medicines Patent Pool (MPP) is a United Nations-backed public health organisation working to increase access to and facilitate the development of life-saving medicines for low- and middle-income countries. Through its innovative business model, MPP partners with civil society, governments, international organisations, industry, patient groups, and other stakeholders to prioritise and license needed medicines and pool intellectual property to encourage generic manufacture and the development of new formulations.
To date, MPP has signed agreements with 22 patent holders for 13 HIV antiretrovirals, one HIV technology platform, three hepatitis C direct-acting antivirals, a tuberculosis treatment, a cancer treatment, four long-acting technologies, a post-partum haemorrhage medicine, three oral antiviral treatments for COVID-19 and 16 COVID-19 technologies.
MPP was founded by Unitaid, which continues to be MPP’s main funder. MPP’s work on access to essential medicines is also funded by the Swiss Agency for Development and Cooperation (SDC), Government of Canada, the World Intellectual Property Organization (WIPO) and the Government of Flanders. MPP’s activities in COVID-19 are undertaken with the financial support of the Japanese Government, the French Ministry for Europe and Foreign Affairs, the German Agency for International Cooperation, and SDC.